HER2 Negative Breast Carcinoma trials recruiting in New Jersey

All HER2 Negative Breast Carcinoma trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
  NCT06678269 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Basking Ridge, Middletown, Montvale
• A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
  NCT07483307 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · New Jersey: Basking Ridge, Middletown, Montvale
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Elizabeth, Hackettstown, Hamilton, Jersey City
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
  NCT07391774 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Cherry Hill, Sewell